Yahoo
OTC Markets OTCPK - Delayed Quote USD

Calithera Biosciences, Inc. (CALA)

0.0001 0.0000 (0.00%)
As of November 5 at 4:00:00 PM EST. Market Open.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2022
12/31/2021
Total Revenue
0
0
9,750
Operating Expense
42,074
42,074
74,308
Operating Income
-42,074
-42,074
-64,558
Net Non Operating Interest Income Expense
477
477
345
Other Income Expense
1,947
1,947
-50,875
Pretax Income
-39,650
-39,650
-115,088
Net Income Common Stockholders
-21,290
-21,290
-115,088
Average Dilution Earnings
-18,360
-18,360
0
Diluted NI Available to Com Stockholders
-39,650
-39,650
-115,088
Basic EPS
-4.60
--
-31.20
Diluted EPS
-7.94
--
-31.20
Basic Average Shares
4,633
--
3,693.4500
Diluted Average Shares
4,992
--
3,693.4500
Total Operating Income as Reported
-42,074
-42,074
-115,433
Total Expenses
42,074
42,074
74,308
Net Income from Continuing & Discontinued Operation
-39,650
-39,650
-115,088
Normalized Income
-41,597
-41,597
-64,213
Interest Income
477
477
345
Net Interest Income
477
477
345
EBIT
-42,074
-42,074
-64,558
EBITDA
-41,819
-41,819
-64,278
Reconciled Depreciation
255
255
280
Net Income from Continuing Operation Net Minority Interest
-39,650
-39,650
-115,088
Total Unusual Items Excluding Goodwill
1,947
1,947
-50,875
Total Unusual Items
1,947
1,947
-50,875
Normalized EBITDA
-43,766
-43,766
-13,403
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2021 - 10/2/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: